Delcath Systems, Inc. (DCTH)
9.95
+0.58
(+6.19%)
USD |
NASDAQ |
Feb 09, 16:00
9.965
+0.02
(+0.15%)
After-Hours: 20:00
Delcath Systems EPS Diluted (Quarterly) : 0.0207 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | 2.150 |
| Danaher Corp. | 1.68 |
| CytoSorbents Corp. | -0.0505 |
| Cardiac Biotech Solutions, Inc. | -0.0025 |
| Odyssey Health, Inc. | -0.0046 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.83M |
| Revenue (Quarterly) | 20.56M |
| Total Expenses (Quarterly) | 19.73M |
| Enterprise Value | 263.42M |
| Gross Profit Margin (Quarterly) | 87.24% |
| Profit Margin (Quarterly) | 4.04% |
| Earnings Yield | 0.09% |
| Operating Earnings Yield | 1.56% |
| Normalized Earnings Yield | 1.555 |